Medexus Pharma Inc Hours

We collected information about Medexus Pharma Inc Hours for you. Follow the liks to find out everything about Medexus Pharma Inc Hours.


Medexus Pharmaceuticals, Inc. (MDP)

    http://www.medexus.com/
    Medexus Pharmaceuticals, Inc. is a leading innovative and rare disease pharmaceutical company with a strong North American commercial platform. From a foundation of proven best in class products we are building a highly differentiated company with a portfolio of innovative and high value orphan and rare disease products that will underpin our ...

Medexus Pharma

    http://www.medexuspharma.com/
    Introducing a world of possibilities in proven therapies. With a focus on advancing and commercializing therapies for autoimmune diseases, cancer, and other near market opportunities with the potential to impact patients’ lives, we strive to use evidence-based medicine to increase the longevity and quality of people’s lives. We have ...

Contact Us – Medexus Pharma

    http://www.medexuspharma.com/contact-us/
    Medexus Pharma, Inc. 29 North Wacker Drive Suite 704 Chicago, IL 60606 Tel. (312-854-0500) Fax. (312-750-1082) For employment verifications, …

Medexus Pharma USA :: Medexus Pharmaceuticals, Inc. …

    https://www.medexus.com/en_US/divisions/medexus-pharma-usa
    A Fully Integrated Specialty Pharmaceutical Company . Medexus Pharma USA is a wholly owned subsidiary of Medexus Pharmaceuticals, Inc. Based in Chicago, Illinois, Medexus Pharma USA focuses on the development and commercialization of novel treatments for autoimmune diseases, oncology, and other near market opportunities.

Contact :: Medexus Pharmaceuticals, Inc. (MDP)

    https://www.medexus.com/en_US/contact
    Medexus Pharmaceuticals, Inc. 35 Nixon Road, Unit 1 Bolton, ON L7E 1K1 Canada. Ken d’Entremont Chief Executive Officer and Director [email protected] 905-676-0800. Marcel Konrad Chief Financial Officer [email protected] 312-548-3139. Business Development or Partnering Inquiries. Michael Pine SVP Business Development & Strategy

Medexus Pharmaceuticals Announces Clear Path to FDA ...

    https://www.medexus.com/en_US/news-media/press-releases/detail/103/medexus-pharmaceuticals-announces-clear-path-to-fda
    TORONTO and CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP) (OTCQX: MEDXF) and medac GmbH (“medac”) announced that medac clarified with FDA details with regard to the projected NDA resubmission of treosulfan, an alkylating agent licensed from medac to Medexus, …

About :: Medexus Pharmaceuticals, Inc. (MDP)

    https://www.medexus.com/en_US/about
    Medexus Pharmaceuticals Inc. is a leading innovative and rare disease pharmaceutical company with a focus on the therapeutic areas of rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases. We provide market-leading prescription and over the counter brands to patients and healthcare professionals, which we ...

Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) | …

    https://www.linkedin.com/company/medexuspharma
    Medexus Pharmaceuticals (TSX: MDP, OTCQX: MEDXF) | 2,609 followers on LinkedIn. Leading North American Specialty Pharmaceutical Company focused on hematology, rheumatology, auto-immune disease ...

Medexus Pharma Inc. Reviews | Glassdoor

    https://www.glassdoor.com/Reviews/Medexus-Pharma-Inc-Reviews-E915978.htm
    Don't offer any training and have unrealistic expectations, zero flexibility with work hours and working from home, yet a few of them don't even live in Chicago where the headquarters is and fly in, sleep in hotels and expense dinners every night. ... Glassdoor has 10 Medexus Pharma Inc. reviews submitted anonymously by Medexus Pharma Inc ...

Medexus Pharmaceuticals Inc expands US product portfolio ...

    https://www.proactiveinvestors.com/companies/news/913981/medexus-expands-us-product-portfolio-by-acquiring-hematology-asset-ixinity-913981.html
    Medexus Pharmaceuticals Inc (CVE:KMDP) (OCTMKTS:PDDPF) said Friday that through its US-based subsidiary, it acquired Aptevo BioTherapeutics LLC, a Delaware company owning the worldwide rights to hematology asset, IXINITY, from Aptevo Therapeutics Inc (NASDAQ:APVO), a biotechnology company developing oncology and hematology drugs.. In a …

Searching for Medexus Pharma Inc Hours?

You can just click the links above. The info is collected for you.

Related Hours Info